Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC
Clinical trial NCT05813522 · UNKNOWN
Trial details
- NCT number
- NCT05813522
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2025-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.